These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12903836)

  • 1. Involvement of the proteasome in IL-1beta induced suppression of islets of Langerhans in the rat.
    Sternesjö J; Karlsen AE; Sandler S
    Ups J Med Sci; 2003; 108(1):37-50. PubMed ID: 12903836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
    Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete protection against interleukin-1beta-induced functional suppression and cytokine-mediated cytotoxicity in rat pancreatic islets in vitro using an interleukin-1 cytokine trap.
    Rydgren T; Bengtsson D; Sandler S
    Diabetes; 2006 May; 55(5):1407-12. PubMed ID: 16644698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1beta-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors.
    Parry GC; Martin T; Felts KA; Cobb RR
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):934-40. PubMed ID: 9633934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets.
    Sternesjö J; Sandler S
    Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway.
    Jeong IK; Oh SH; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
    Exp Mol Med; 2002 Mar; 34(1):12-7. PubMed ID: 11989973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
    Rydgren T; Sandler S
    Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells.
    Andersson AK; Sandler S
    J Pineal Res; 2001 Apr; 30(3):157-65. PubMed ID: 11316326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1beta.
    Ye J; Laychock SG
    Endocrinology; 1998 Oct; 139(10):4155-63. PubMed ID: 9751495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
    Sternesjö J; Sandler S
    J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
    Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta.
    Scarim AL; Heitmeier MR; Corbett JA
    Endocrinology; 1997 Dec; 138(12):5301-7. PubMed ID: 9389514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
    Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
    Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
    Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
    Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
    Shen X; Tian Z; Holtzman MJ; Gao B
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
    Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
    Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprusside and interleukin-1beta mediated suppression--possible involvement of the mitochondrial membrane potential.
    Kullin M; Li Z; Bondo Hansen J; Welsh N; Karlsson FA; Sandler S
    Diabetologia; 2003 Jan; 46(1):80-8. PubMed ID: 12637986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
    Andersson AK; Flodström M; Sandler S
    Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.